MISONIX, Inc. (MSON): Price and Financial Metrics


Today's Latest Price: $14.80 USD

0.00 (0.00%)

Updated Nov 24 4:00pm

Add MSON to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

MSON Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, Misonix Inc is reporting a growth rate of 201.29%; that's higher than 93.12% of US stocks.
  • Revenue growth over the past 12 months for Misonix Inc comes in at 69.99%, a number that bests 92.68% of the US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MSON comes in at -22.72% -- higher than that of just 14.96% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Misonix Inc, a group of peers worth examining would be ARTW, NTWK, CVV, IKNX, and XGN.
  • Visit MSON's SEC page to see the company's official filings. To visit the company's web site, go to www.misonix.com.

MSON Stock Price Chart Interactive Chart >

Price chart for MSON

MSON Price/Volume Stats

Current price $14.80 52-week high $21.90
Prev. close $14.80 52-week low $6.71
Day low $14.49 Volume 94,700
Day high $15.19 Avg. volume 83,230
50-day MA $12.21 Dividend yield N/A
200-day MA $12.54 Market Cap 257.19M

MSON Latest News Stream

Event/Time News Detail
Loading, please wait...

MSON Latest Social Stream

Loading social stream, please wait...

View Full MSON Social Stream

Latest MSON News From Around the Web

Below are the latest news stories about Misonix Inc that investors may wish to consider to help them evaluate MSON as an investment opportunity.

Misonix adds TheraGenesis to its wound product portfolio

Misonix ([[MSON]] -6.9%) enters into exclusive supply and distribution agreement with Gunze Limited for TheraGenesis Bilayer Wound Matrix, a FDA cleared matrix with a silicone film layer used to treat trauma, burn and reconstructive wounds.The company notes TheraGenesis compliments Misonix’s current tissue regeneration wound portfolio of TheraSkin and SonicOne and allows to gain market...

Seeking Alpha | September 21, 2020

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q4 2020 Results - Earnings Call Transcript

Start Time: 16:30 End Time: 17:06 Misonix, Inc. (MSON) Q4 2020 Earnings Conference Call September 03, 2020, 16:30 PM ET Company Participants Stavros Vizirgianakis - CEO Joseph Dwyer - CFO Norberto Aja - IR Conference Call Participants Kyle Rose - Canaccord Genuity Ryan Zimmerman - BTIG Alex Nowak - Craig-Hallum...

SA Transcripts on Seeking Alpha | September 4, 2020

Misonix to Present at the 40th Annual Canaccord Genuity Growth Conference

FARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 40th Annual Canaccord Genuity Growth Conference. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Misonix Chief Financial Officer, will be making a virtual company presentation on Wednesday, August 12th at 10:30 a.m. ET. Management will also be available to speak with institutional investors in one-on-one virtual meetings throughout the day on August 12th and 13th. If you have questions about Misonix or are interested in conducting a conference call or meeting with management, please contact the ...

Yahoo | July 30, 2020

What Percentage Of Misonix, Inc. (NASDAQ:MSON) Shares Do Insiders Own?

If you want to know who really controls Misonix, Inc. (NASDAQ:MSON), then you'll have to look at the makeup of its...

Yahoo | July 10, 2020

Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 Million

Full Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational.

Yahoo | July 10, 2020

Read More 'MSON' Stories Here

MSON Price Returns

1-mo 20.72%
3-mo 9.23%
6-mo 6.25%
1-year -27.84%
3-year 37.67%
5-year 54.01%
YTD -20.47%
2019 16.24%
2018 69.42%
2017 -9.57%
2016 11.17%
2015 -24.01%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.1752 seconds.